- SEK15.82bn
- SEK16.69bn
- SEK3.44bn
Brief: Vitrolife Expands Its Genomics Business To Asia Pacific Region
Brief: Vitrolife Q3 EBITDA Rises To SEK 162 Mln
Brief: Vitrolife Appoints Patrik Tolf As New CFO
Brief: Vitrolife's CFO Leaves
Brief: Vitrolife's Share Buyback Program Completed
Brief: Vitrolife Q2 EBITDA Rises To SEK 134 Million
Brief: Vitrolife AB Launches Share Buybacks
Brief: Vitrolife Prelim Q2 EBITDA Up At SEK 134 Mln
Brief: Vitrolife Completes Directed Share Issue Of 9.6 Million Shares, Raising Proceeds Of Approximately SEK 3.6 Bln
Sweden's Vitrolife to buy Igenomix in EUR 1.25 bln deal
Brief: Vitrolife Buys Genetic Testing Services Provider Igenomix
Brief: Vitrolife Q1 EBITDA Up At SEK 163 Million
Brief: Conference Call Interim Report
Brief: Vitrolife Q4 EBITDA Rises To SEK 164 Million
Brief: Vitrolife Q3 EBITDA Down At SEK 134 Mln
Brief: Vitrolife Q2 EBITDA Down At SEK 40 Million
Brief: Vitrolife Says No Dividend For Financial Year 2019 Will Be Paid In Accordance With Proposal From Board
Brief: Vitrolife Updates On Impact Of COVID-19 On Co's Sales
Brief: Vitrolife Q1 EBITDA Falls To SEK 116 Million